Skip to content
Trial Eligibility
Menu

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

NCT06951217

This study is recruiting at 31 US sites in 21 states, according to its ClinicalTrials.gov record last updated .

Summary

This is an open-label extension study for participants who were previously enrolled in and completed an Avalyn Pharma Sponsored study with an inhaled antifibrotic, such as AP01. Eligible participants will have their final dose of drug at the end of study visit from the lead-in study and first AP-LTE-008 study visit on the same day.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Progressive Pulmonary Fibrosis
  • Idiopathic Pulmonary Fibrosis (IPF)

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Avalyn Pharma Inc.
Last updated on ClinicalTrials.gov
October 2, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alabama · 1

  • University of Alabama at Birmingham · Birmingham, AL

California · 2

  • University of Southern California · Los Angeles, CA
  • Newport Native MD, Inc. · Newport Beach, CA

Colorado · 1

  • University of Colorado, Anschutz Medical Campus · Aurora, CO

Connecticut · 1

  • Yale University · New Haven, CT

Florida · 1

  • Renstar Medical Research · Ocala, FL

Georgia · 1

  • Piedmont Healthcare, Inc. · Atlanta, GA

Kansas · 1

  • The University of Kansas Medical Center · Kansas City, KS

Maryland · 2

  • Johns Hopkins Asthma and Allergy Center · Baltimore, MD
  • University of Maryland · Baltimore, MD

Minnesota · 1

  • Mayo Clinic Rochester · Rochester, MN

Missouri · 1

  • Hannibal Regional Healthcare System, Inc. · Hannibal, MO

New York · 3

  • Columbia University · New York, NY
  • Icahn School of Medicine at Mount Sinai · New York, NY
  • Weill Cornell · New York, NY

North Carolina · 2

  • Piedmont HealthCare, PA · Statesville, NC
  • Southeastern Research Center · Winston-Salem, NC

Ohio · 1

  • University of Cincinnati · Cincinnati, OH

Oregon · 2

  • Summit Health · Bend, OR
  • The Oregon Clinic Pulmonary East · Portland, OR

Pennsylvania · 2

  • Temple University Hospital · Philadelphia, PA
  • Thomas Jefferson University · Philadelphia, PA

South Carolina · 2

  • Lowcountry Lung and Critical Care, PA · Charleston, SC
  • Medical University of South Carolina · Charleston, SC

Tennessee · 1

  • Vanderbilt University Medical Center · Nashville, TN

Texas · 2

  • El Paso Pulmonary Association, P.A. · El Paso, TX
  • Baylor College of Medicine · Houston, TX

Utah · 2

  • Intermountain Medical Center · Murray, UT
  • University of Utah · Salt Lake City, UT

Virginia · 1

  • Inova Healthcare · Falls Church, VA

Washington · 1

  • University of Washington · Seattle, WA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.